Search

Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.

This cross-sectional study found that, after the state-level legalization of cannabis for recreational use in California, greater retail availability was associated with higher odds of cannabis use among pregnant women; these results were...

Abstract

Importance  People experiencing homelessness have been disproportionately affected by the opioid overdose crisis. To mitigate morbidity and mortality, several office-based addiction treatment (OBAT) programs designed for this...

Abstract

Importance  A persistently high US drug overdose death toll and increasing health care use associated with substance use disorder (SUD) create urgency for comprehensive estimates of attributable direct costs, which can assist in...

Abstract

Objective

Recovery community centers (RCCs) have expanded across the U.S., serving as social “recovery hubs” that increase recovery capital (e.g., employment, housing) by providing resources that clinical care does not provide...

Abstract

Importance: Hypertension is a leading cause of cardiovascular disease in adults; preclinical associations between hypertension and cardiovascular disease are seen in childhood. Nicotine is a known toxin, but its association with...

Abstract

Importance: The US Food and Drug Administration (FDA) is required to communicate the risks of tobacco constituents to the public. Few studies have addressed how FDA media campaigns can effectively communicate about cigarette smoke...

During the COVID-19 pandemic, social distancing measures have made in-person mutual help groups inaccessible to many individuals struggling with substance use disorders (SUDs). In this paper, we share our experience training volunteers to facilitate SMART Recovery groups and SMARTline

A cross-country group of researchers funded by NIDA has identified needed areas of research related to the intertwining epidemics of HIV, COVID-19 and the increasing use of methamphetamine in the United States among men who have sex with...

On 26th January, ISSUP Global supported a Webinar on the topic of the Role of Persuasion in Media-based Substance Prevention, with presentations from the Claremont Graduate University Media-Based Prevention Science Certificate Program Trainees, 2018-Present.

Join us for this free virtual summit featuring Ms. Giovanna Campello, Chief, UNODC Prevention, Treatment and Rehabilitation Section, and Dr. Robert DuPont, President, Institute for Behavior and Health, Inc. and First Director, U.S. National...

New study sheds light on COVID-19 vaccine readiness among individuals with substance use disorder (SUD). In a small sample of individuals with SUD, some are hesitant to receive the vaccine out of fear of injection triggers.

On December 15, the United States National Institute on Drug Abuse announced new data from the annual Monitoring the Future study led by researchers at the University of Michigan.

On December 16, a data processing error was found. This...

Our recently released short video, The Impact of Drugs in the Workplace, is now available in Spanish!

Our recently released The Environmental Impact of Drugs... Know the Truth short animated video is now available in Spanish!

Our recently released Protective Factors video is now available in Spanish!

Our new Alternatives to Incarceration short video is now available in Spanish!